AMANDA FINLAYSON: Open Payments
NPI 1740773829 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,314 in 85 payments from 32 companies in 2025. Trend: 2023 $2,402 · 2024 $1,739 · 2025 $2,314
Food & beverage: $1,974Education: $340
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $479 |
| GlaxoSmithKline, LLC. | 9 | $216 |
| AstraZeneca Pharmaceuticals LP | 5 | $197 |
| Merck Sharp & Dohme LLC | 5 | $129 |
| Daiichi Sankyo Inc. | 2 | $120 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| SEAGEN INC. | 1 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| PharmaEssentia USA Corporation | 3 | $77 |
| Ipsen Biopharmaceuticals, Inc | 1 | $61 |
Products named: ERLEADA, DARZALEX, LYNPARZA, Enhertu, JEMPERLI, KEYTRUDA, OJJAARA, CARVYKTI.
Industry payments across AZ — which companies pay providers there.
